Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1856 of 6351
-
Can family bonds help teens beat HIV stigma?
Disease control CompletedThis study will evaluate the impact of Family Connections, a family-based group intervention for adolescents and young adults (AYA) living with HIV and their family caregivers, on achieving HIV self-management defined as having an undetectable viral load (VL) and low self-stigma …
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New surgical wash aims to cut joint infection risk in 7,600 replacement patients
Disease control Recruiting nowA prospective, multi-center, double-arm, parallel, interventional, randomized, controlled clinical trial to assess the rate of periprosthetic joint infection (PJI) in patients undergoing primary total knee arthroplasty (TKA), total hip arthroplasty (THA) or hip resurfacing (HR) w…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can muscle oxygen levels reveal Parkinson's exercise limits?
Knowledge-focused CompletedThe primary aim of this study is to compare maximum and functional exercise capacity and muscle oxygenation during exercise test in patients with Parkinson's disease. The secondary aim is to evaluate respiratory functions, respiratory muscle strength and endurance, peripheral mus…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Sound waves zap kidney stones: no needle, no knife needed
Disease control Recruiting nowThis is a prospective, open-label, multi-center study to test the clinical feasibility of facilitating stone passage by the combination of breaking and repositioning stones with ultrasound, without the need for anesthesia.
Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
Diagnosis Completed99mTc-nanocolloid, the world wide used hybrid tracer for dynamic sentinel node biopsy, has recently been replaced with 99mTc-nanoscan. The hybrid form (ICG-99mTc-nanoscan) has not yet been validated, to show the similarity between the lymphatic drainage pattern between ICG-99mTc-…
Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
New injection could ease swallowing for eosinophilic esophagitis patients
Disease control Recruiting nowA Phase 1b/2 study to explore the safety, efficacy and pharmacokinetics of EP-104GI in adults with eosinophilic esophagitis (EoE). Endoscopic and histologic assessments will also be evaluated to understand the local effects of EP-104GI on eosinophilic EoE disease activity. Approx…
Phase 1/2 • Sponsor: Eupraxia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Smartphone apps show promise for Schizophrenia's 'Negative' symptoms
Symptom relief CompletedThis study evaluates the efficacy of two prescription digital therapeutics (PDT) in addition to standard of care (SOC) therapy for the treatment of experiential negative symptoms of schizophrenia in late adolescents and adults.
Phase 3 • Sponsor: Click Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New combo therapy shows promise for Tough-to-Treat endometrial cancer
Disease control OngoingThis phase Ib/II trial tests the safety, side effects, best dose, and effectiveness of the combination of ipatasertib with megestrol acetate to megestrol acetate alone in patients with endometrial cancer that has come back (recurrent) or has spread to other places in the body (me…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Zapping pancreatic tumors with heat: a new hope?
Disease control Recruiting nowThis is a single arm study in the treatment of pancreatic ductal adenocarcinoma (PDAC). The investigators propose to test the tolerability of chemotherapy plus endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) using the RF Electrode in patients receiving palliative s…
Phase 1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Door-to-Door help may increase COVID testing in Hard-to-Reach communities
Prevention CompletedAntigen self-testing kits are more available at this stage in the pandemic, but among vulnerable populations, use is still low and instructions for antigen testing are not typically designed for low health literacy populations. Studies are needed to explore access and use of anti…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Weight training cuts fall risk in 80+ seniors, study finds
Disease control OngoingThis study will investigate the effects of 12 months of high-intensity progressive resistance training compared with a control group on fall-rate in older adults with sarcopenia.
Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Supplement epidiferphane aims to ease Chemo's harsh side effects
Symptom relief Recruiting nowPatients with breast cancer are commonly treated with taxane chemotherapy. Some very common side effects of taxanes, such as anemia and peripheral neuropathy, are often as not well addressed during treatment, resulting in dose reductions, dose delays and early discontinuation (co…
Phase 1/2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Shockwave breakthrough opens door for heart valve fix in Hard-to-Treat patients
Symptom relief Recruiting nowTo assess the efficacy and safety of Intravascular Lithotripsy (IVL) in subjects undergoing transfemoral TAVR in patients with severe iliac disease, prohibitive for transfemoral TAVR in patients with severe symptomatic aortic stenosis, otherwise considered for alternative access …
Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New gene therapy aims to tame PKU in first human test
Disease control OngoingThis is a single-center, open-label, non-randomized, dose escalation study to evaluate the safety, tolerability and efficacy of NGGT002 in adult Phenylketonuria (PKU) subjects. All subjects will receive a single administration of NGGT002 and will be followed for safety and effica…
Early phase 1 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for IBS sufferers: allergy drug may beat standard treatment
Symptom relief Recruiting nowMulticenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome Trial rationale 1. To perform a randomized superiority trial comparing the clinical efficacy of ebastine and mebeverine 2. To evaluate the impact of treat…
Phase 3 • Sponsor: Guy Boeckxstaens • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedA study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
Phase 3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Eye blood flow camera could spot glaucoma before vision fades
Diagnosis Recruiting nowThe goal of this clinical trial is to investigate the use of an FDA-cleared retinal blood flow imaging instrument called the XyCAM RI and XyCAM FC (Vasoptic Medical, Inc., Columbia, MD) in glaucoma management. The main question it aims to answer are: * Can the investigators use…
Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New drug AU409 enters first human trial for tough liver cancers
Disease control PausedThis phase I trial tests the safety, side effects, and best dose of a new intervention, AU409, in treating patients with primary liver cancers that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or advanced solid…
Phase 1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a simple pacing upgrade help heart failure patients who Don't qualify for standard therapy?
Disease control Recruiting nowCardiac Resynchronization Therapy (CRT) decreases heart failure hospitalizations and mortality and increases left ventricular Ejection Fraction (EF) in patients with dilated cardiomyopathy, left bundle branch block and QRS duration \>130msec. His bundle pacing has a similar effec…
Sponsor: Miulli General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could african plant extracts be the next Weight-Loss breakthrough?
Disease control OngoingObesity is a global health crisis affecting over 2.3 billion individuals worldwide. This prospective study aims to evaluate the comparative effects of standardised Cissus quadrangularis extract (CQE) and Dichrostachys glomerata extract (DGE) on obesity-related parameters, focusin…
Phase 1/2 • Sponsor: University of Yaounde 1 • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC